ARDELYX, INC. Proceeds from Royalties Received
ARDELYX, INC. (ARDX) reported Proceeds from Royalties Received of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRoyaltiesReceived · last filed 2024-05-02
- ARDELYX, INC. proceeds from royalties received for the quarter ending 2024-03-31 was $0.00.
- ARDELYX, INC. proceeds from royalties received for the quarter ending 2023-12-31 was $0.00.
- ARDELYX, INC. proceeds from royalties received for the quarter ending 2023-09-30 was $0.00.
- ARDELYX, INC. proceeds from royalties received for the quarter ending 2023-06-30 was $0.00.
- ARDELYX, INC. proceeds from royalties received for fiscal 2023 was $0.00.
- ARDELYX, INC. proceeds from royalties received for fiscal 2022 was $0.00.
| Period end | Proceeds from Royalties Received 3 month | Proceeds from Royalties Received 6 month | Proceeds from Royalties Received 9 month | Proceeds from Royalties Received 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2024-05-02 | $0.00 derived: sum of 3 quarters · filed 2024-05-02 | $0.00 derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $0.00 derived: sum of 2 quarters · filed 2023-10-31 | $0.00 10-Q · filed 2023-10-31 | $0.00 derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | $0.00 derived: sum of 3 quarters · filed 2023-08-02 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2023-05-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |